stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 38.15

+0.75 (+2.01)%

GBX 0.21B

0.99M

N/A

N/A

Icon

APH:LSE

Alliance Pharma plc (GBX)
COMMON STOCK | LSE
GBX 38.15
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.21B

N/A

GBX 38.15

Alliance Pharma plc Stock Forecast

N/A

Based on the Alliance Pharma plc stock forecast from 0 analysts, the average analyst target price for Alliance Pharma plc is not available over the next 12 months. Alliance Pharma plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Alliance Pharma plc is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, Alliance Pharma plc’s stock price was GBX 38.15. Alliance Pharma plc’s stock price has changed by -0.78% over the past week, -2.43% over the past month and -19.26% over the last year.

No recent analyst target price found for Alliance Pharma plc
No recent average analyst rating found for Alliance Pharma plc

Company Overview Alliance Pharma plc

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medica...Read More

Avonbridge House, Chippenham, United Kingdom, SN15 2BB

285

December

GBX

UK

Adjusted Closing Price for Alliance Pharma plc (APH:LSE)

Loading...

Unadjusted Closing Price for Alliance Pharma plc (APH:LSE)

Loading...

Share Trading Volume for Alliance Pharma plc Shares

Loading...

Compare Performance of Alliance Pharma plc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for APH:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Alliance Pharma plc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HLN:LSE
Haleon PLC -4.30 (-1.28%) GBX30.58B 24.65 27.40

ETFs Containing APH

Symbol Name APH's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Alliance Pharma plc (APH:LSE) Stock

Stock Target Advisor's fundamental analysis for Alliance Pharma plc's stock is Slightly Bearish.

APH:LSE stock's dividend yield is 3.75%. Our analysis grades APH:LSE stock's dividend yield at F. This means that APH:LSE stock's dividend yield is above 58% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the LSE exchange. Based on this APH:LSE may be a average dividend stock for its sector.

Unfortunately we do not have enough data on APH:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on APH:LSE's stock to indicate if its overvalued.

The last closing price of APH:LSE's stock was GBX 38.15.

The most recent market capitalization for APH:LSE is GBX 0.21B.

Unfortunately we do not have enough analyst data on APH:LSE's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...